Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC Vaccine with or without Cisplatin in Melanoma
NCT02285413Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2011
- Primary completion
- Oct 2015
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dendritic cell-Cantonal Hospital of St. Gallen-prostate cancer in melanoma, sponsored by Radboud University Medical Center. Started Feb 2011; status: completed.
02
Drugs
dendritic cell-Cantonal Hospital of St. Gallen-prostate cancer
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02285413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02285413.